Business & Finance
Pharming Group's unaudited net loss narrows to EUR10.0m in 2015
10 March 2016 -

Pharmaceutical company Pharming Group NV (Euronext Amsterdam:PHARM) announced on Wednesday its (unaudited) net loss of EUR10.0m for the full year ended 31 December 2015.

This marks a significant improvement when compared to the loss of EUR21.8m in 2014, excluding the one-off licensing income of EUR16.0m in 2014.

Unaudited revenues from product sales of EUR8.6m was collected in 2015, up from EUR3.0m in 2014 mainly as a result of a full year's sales in the US.Total revenues dropped to EUR10.8m (including EUR2.2 m of license revenue) in 2015 from EUR21.2m (including EUR18.2m in license revenue) in 2014.

The company's operating result rose slightly to an unaudited loss of EUR12.8m from a loss of EUR13.1m in 2014 (excluding the one-off license income in 2014), in spite of a considerable increase in R&D activity in 2015.

Login
Username:

Password: